Actinium Pharmaceuticals, Inc.(NYSE Amex Equities : ATNM)
(
)
Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen Inc. | 0.17% | 203.56 | 1.3% | $427.08m | |
| BIIB | Biogen Inc. | -0.93% | 225.60 | 1.3% | $388.53m | |
| GILD | Gilead Sciences, Inc. | -0.35% | 65.00 | 0.9% | $366.13m | |
| CELG | Celgene Corporation | 0.82% | 101.80 | 1.3% | $356.32m | |
| ILMN | Illumina, Inc. | 0.28% | 310.55 | 3.5% | $253.40m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.73% | 301.57 | 2.6% | $219.86m | |
| EXAS | Exact Sciences Corporation | -0.20% | 97.39 | 24.1% | $203.99m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 0.48% | 99.99 | 2.0% | $181.39m | |
| VRTX | Vertex Pharmaceuticals Incorporated | 0.93% | 177.72 | 1.9% | $178.93m | |
| A | Agilent Technologies, Inc. | -0.47% | 74.92 | 1.6% | $143.96m | |
| SRPT | Sarepta Therapeutics, Inc. | 0.81% | 87.44 | 14.6% | $138.15m | |
| BMRN | BioMarin Pharmaceutical Inc. | -0.06% | 67.90 | 4.3% | $95.86m | |
| SGEN | Seattle Genetics, Inc. | 2.48% | 85.94 | 6.2% | $90.55m | |
| NKTR | Nektar Therapeutics | 1.31% | 17.77 | 5.5% | $84.92m | |
| ALDR | Alder Biopharmaceuticals, Inc. | 0.16% | 18.90 | 10.2% | $83.36m |
Company Profile
Actinium Pharmaceuticals, Inc. is a clinical-stage, Biopharmaceutical Company focused on developing and potentially commercializing therapies to cell therapies. The firm's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest in order to kill those cells. Its product pipeline includes Iomab-B, Actimab-A, and Actimab-M. The company was founded in 1993 and is headquartered in New York, NY.